| |
| |
|
| Insider
Information: |
Alnylam Pharmaceuticals, Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
4,896,716 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,234,136 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,896,716 |
|
|
| Total
Value |
$10,234,136 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
2016-02-23 |
4,896,716 |
2012-10-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2016-02-23 |
4 |
S |
$7.18 |
$7,180,000 |
D/D |
(1,000,000) |
4,896,716 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-24 |
4 |
AS |
$15.19 |
$28,109 |
D/D |
(1,850) |
5,896,716 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-23 |
4 |
AS |
$14.24 |
$24,202 |
D/D |
(1,700) |
5,898,566 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-22 |
4 |
AS |
$14.00 |
$1,533,125 |
D/D |
(109,534) |
5,900,266 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-17 |
4 |
AS |
$6.79 |
$20,371 |
D/D |
(3,000) |
6,009,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-16 |
4 |
AS |
$6.76 |
$32,450 |
D/D |
(4,800) |
6,012,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-15 |
4 |
AS |
$6.67 |
$28,687 |
D/D |
(4,300) |
6,017,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-10 |
4 |
AS |
$6.41 |
$12,813 |
D/D |
(2,000) |
6,021,900 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-09 |
4 |
AS |
$6.58 |
$31,238 |
D/D |
(4,750) |
6,023,900 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-08 |
4 |
AS |
$6.63 |
$21,888 |
D/D |
(3,300) |
6,028,650 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-03 |
4 |
AS |
$6.88 |
$22,688 |
D/D |
(3,300) |
6,031,950 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-02 |
4 |
AS |
$6.64 |
$24,903 |
D/D |
(3,750) |
6,035,250 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-10-01 |
4 |
AS |
$6.71 |
$21,808 |
D/D |
(3,250) |
6,039,000 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-26 |
4 |
AS |
$7.04 |
$17,598 |
D/D |
(2,500) |
6,042,250 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-25 |
4 |
AS |
$7.12 |
$17,790 |
D/D |
(2,500) |
6,044,750 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-24 |
4 |
AS |
$7.19 |
$26,978 |
D/D |
(3,750) |
6,047,250 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-19 |
4 |
AS |
$7.22 |
$29,587 |
D/D |
(4,100) |
6,051,000 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-18 |
4 |
AS |
$7.40 |
$11,098 |
D/D |
(1,500) |
6,055,100 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-17 |
4 |
AS |
$7.43 |
$15,610 |
D/D |
(2,100) |
6,056,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-12 |
4 |
AS |
$7.96 |
$27,861 |
D/D |
(3,500) |
6,058,700 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-11 |
4 |
AS |
$7.83 |
$26,636 |
D/D |
(3,400) |
6,062,200 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-10 |
4 |
AS |
$7.70 |
$15,399 |
D/D |
(2,000) |
6,065,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-05 |
4 |
AS |
$7.07 |
$16,974 |
D/D |
(2,400) |
6,067,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-04 |
4 |
AS |
$7.11 |
$42,656 |
D/D |
(6,000) |
6,070,000 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-09-03 |
4 |
AS |
$6.95 |
$11,471 |
D/D |
(1,650) |
6,076,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
